医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

AECOM awarded project management contract for redevelopment of Kwong Wah Hospital in Hong Kong

2013年08月01日 PM08:25
このエントリーをはてなブックマークに追加


 

LOS ANGELES

AECOM Technology Corporation (NYSE: ACM), a leading provider of professional technical and management support services for public and private clients in more than 140 countries around the world, announced today that AECOM has been awarded a project management contract for the redevelopment of the Kwong Wah Hospital, one of the major acute hospitals in the Hong Kong Hospital Authority’s Kowloon West Cluster.

The redevelopment plan aims to expand the capacity of the hospital to meet the increasing demand for health care services in the Kowloon West Cluster.

The contract follows AECOM being awarded similar work on the expansion project for the nearby United Christian Hospital during 2012.

“We are proud to win our second major health care project from the Hong Kong Hospital Authority within the last year,” said John M. Dionisio, AECOM chairman and chief executive officer. “This assignment clearly demonstrates AECOM’s strength within the health care sector, reflecting our innovative work in this area.”

AECOM will also represent the Hospital Authority as the manager of other design consultants throughout the Kwong Wah Hospital redevelopment’s project period, as well as the resident site staff throughout construction.

The redevelopment is scheduled for completion during 2022.

About AECOM

AECOM is a global provider of professional technical and management support services to a broad range of markets, including transportation, facilities, environmental, energy, water and government. With approximately 45,000 employees around the world, AECOM is a leader in all of the key markets that it serves. AECOM provides a blend of global reach, local knowledge, innovation and technical excellence in delivering solutions that create, enhance and sustain the world’s built, natural, and social environments. A Fortune 500 company, AECOM serves clients in more than 140 countries and had revenue of $8.2 billion during the 12 months ended March 31, 2013. More information on AECOM and its services can be found at www.aecom.com.

Forward-Looking Statements: All statements in this press release other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, statements of plans for future operations or expected revenue. Actual results could differ materially from those projected or assumed in any of our forward-looking statements. Important factors that could cause actual results to differ materially from our forward-looking statements are set forth in our quarterly report on Form 10-Q for the fiscal quarter ended March 31, 2013, and our other reports filed with the U.S. Securities and Exchange Commission. AECOM does not intend, and undertakes no obligation, to update any forward-looking statement.

NR 13-0801

CONTACT

Media:
AECOM Technology Corporation
Paul Dickard,
646-432-8473
VP, External Communications
Paul.Dickard@aecom.com

同じカテゴリーの記事 

  • ATLATL Scientific and Miltenyi Biotec: A Five-Year Partnership Driving Biotech Innovation in Singapore and Beyond
  • 世界経済フォーラム(WEF)特別会合リヤドが閉幕平和と繁栄への明確で不可逆的な道をグローバルな最優先課題とすることを呼びかける
  • 世界经济论坛特别会议闭幕,全球领导人呼吁:探寻通往和平与繁荣的清晰、不可逆转路径应为全球首要任务
  • Aurion Biotech Announces Completion of Enrollment in Phase 1 / 2 Clinical Trial
  • PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis